| Product Name |
Dabigatran Etexilate Mesilate (Ph.Eu. 33.3) Impurity B
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Heterocycles, Pharmaceutical Standards, Fine Chemicals, Aromatics, Amines |
| CAS No |
429658-95-7 |
| Catalog Number |
GS.01.DAB.02EM |
| Chemical Name/Synonyms |
Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate; N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine Ethyl Ester;Dabigatran JPBA Impurity 3; 3-({2-[(4-Carbamimidoyl-phenylamino)-methyl]-1-methyl-1H-benzoimidazole-5-carbonyl}-pyridin-2-yl-amino)-propionic Acid Ethyl Ester; Dabigatran Ethyl Ester (As per USP Commenting Opening 52(2)); |
| Molecular Weight |
499.56 |
| Molecular Formula |
C27H29N7O3 |
| Purity |
NLT 95 % |
| Applications |
Used to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. |
| Inventory Status |
customized
|
